Adding Erlotinib to Chemoradiation Improves Overall Survival but Not Progression-Free Survival in Stage III Non-Small Cell Lung Cancer
- Resource Type
- Article
- Source
- In
International Journal of Radiation Oncology, Biology, Physics 1 June 2015 92(2):317-324 - Subject
Thoracic Cancer - Language
- ISSN
- 0360-3016